Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C

Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C

COVID-19 has infected more than 275 million worldwide (at the beginning of 2022). Children appear less susceptible to COVID-19 and present with milder symptoms. Cases of children with COVID-19 developing clinical features of Kawasaki-disease have been described. Here we utilise Mass Spectrometry pro...

Full description

Bibliographic Details
Main Authors: Attard, C. (Author), Bhatnagar, A. (Author), Bonnet, D. (Author), Borgel, D. (Author), Cai, T. (Author), Ignjatovic, V. (Author), Karlaftis, V. (Author), Lasne, D. (Author), Letunica, N. (Author), McCafferty, C. (Author), Monagle, P. (Author), Praporski, S. (Author), Renolleau, S. (Author), Song, X. (Author), Van Den Helm, S. (Author), Vedrenne-Cloquet, M. (Author), Wu, J. (Author), Zaw, T. (Author)
Format: Article
Language:English
Published: Nature Research 2022
Subjects:
complement
Complement System Proteins
complication
COVID-19
human
Humans
procedures
proteomics
Proteomics
respiratory distress syndrome
Respiratory Distress Syndrome
systemic inflammatory response syndrome
Systemic Inflammatory Response Syndrome
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items